OMNISENSE 7000S

with parts & labor warranty
plus free add-ons

Own a Omnisense 7000S and get additional
add-ons
free market kit (see email)
  free applications training
  free second probe               

YOUR EDGE IN THE FIGHT AGAINST OSTEOPOROSIS

OMNIPATH™ TECHNOLOGY
INNOVATIVE

FINALLY, BONE STRENGTH ASSESSMENT YOU CAN RELY ON

Sunlight's innovative and patented axial transmission technology, Omnipath™, uniquely measures Speed of Sound waves propagating along the bone's maximal strength axis.

OMINIPATH'S AXIAL TRANSMISSION TECHNOLOGY

Accurate
Precise
Elimates soft tissue effects
Comprehensive bone strength assessment

THERE IS MORE TO BONE THAT DENSITY

Omnipath's unique Speed of Sound measurements reflect multiple bone properties for a comprehensive assessment:

Bone Mineral Density
Elasticity
Cortical thickness
Micro-architecture

MULTI-SITE MEASUREABLE

Multi-Site Advantage
Omnisense's unique probe technology is the only one of its kind. By enabling multi-site measurements, the Omnisense probe system provides you with greater diagnostic ability and enhanced measurement flexibility.

Getting The Whole Picture
Due to the systemic nature of Osteoporosis, having a multiple site option provides an overall picture of the skeleton and offers many advantages to the physician:

  Combining measurement results of different skeletal sites can optimize fracture risk assessment.

  Using multiple measurement sites enables the physician to overcome the dilemma of how to diagnose patients who:
       have a clinical indication of osteoporosis but whose
           measurement results do not support this.
       are not clearly defined and require a more
           conclusive diagnosis.

Monitoring Response To Treatment
Different bones respond to treatment at varying rates and degrees. Using multi-site measurements, the physician can identify and monitor small bone changes in a relatively short period of time, allowing more effective monitoring and treatment decisions.

CLINICAL RESULTS
PROVEN

An impressive body of clinical evidence supports the efficacy of Omnisense. The collected data demonstrate excellent precision, fracture discrimination and prediction ability as well as high sensitivity to bone changes caused by treatment or metabolic diseases.

ACCURACY
Comparison studies between Omnisense and DXA of fractured and non-fractured subjects demonstrate Omnisense's enhanced capability to correctly classify osteoporotic patients (high sensitivity).3-7

HIP FRACTURE PREDICTION
A number of clinical studies substantiate that Omnisense measurements at the distal 1/3 radius and phalanx reliably predict hip fractures.3-7

MONITORING BONE CHANGES
Omnisense monitors bone changes due to bone related disorders and in response to treatment.

COMPARISON OF SOS VALUES FOR TREATED VS. NON -TREATED PATIENTS9

As expected, the SOS values were higher for those patients being treated with Hormone Replacement Therapy. This demonstrates Omnisense sensitivity to bone changes in response to treatment.

The SOS measured by Omnisense has a precision error low enough in comparison with the expected annual change in a patient's measurement to make it suitable for monitoring bone changes which occur in the early years following menopause."8

WHO COMPLIANT
Omnisense results are compatible with World Health Organization criteria for osteoporosis diagnosis. Results are automatically compared to a selectable built-in reference database and are expressed as T-Scores and Z-Scores.

RESULTS YOU CAN TRUST

• Accurate
• High Precision (0.4% CV)
• Monitors bone changes
• Fracture prediction
• Compatible with WHO criteria

THE PHYSICIAN'S
SOLUTION

SCREENING--DIAGNOSING--MONITORING
Osteoporosis has reached epidemic proportions; as a physician you see at risk patients on a daily basis. The availability of effective treatment continually drives the demand for more accurate osteoporosis diagnosis.

Omnisense 7000S answers the growing need for a cost-effective, comprehensive bone strength assessment solution without compromising accuracy or precision. The only ultrasonic multi-site bone assessment device available today, Omnisense 7000S represents a significant development in the fight against osteoporosis.

DESIGNED FOR YOUR CLINIC
Compact and powerful, Omnisense 7000S provides lifelong bone strength evaluation and follow-up.

Its ease of use and comfortable, patient-friendly nature ensure that Omnisense 7000S is the up and coming bone strength assessment alternative.

TOTAL SOLUTION

• Affordable
• Easy to use
• Radiation-free
• Fast - one minute testing
• Compact and convenient
• Built-in patient data management and scheduling
• Male and female reference database

The Omnisense Measurement Report printout highlights all relevant information in an easy-to-understand format.

• Easy-to-read colored graph
• Patient measurement history
• Patient information
• T and Z Score results
• Space for comments and recommendations

REFERENCES

1.    Hans, D. et al., "Does Combining the Results from Multiple Bone Sites Measured by a New Quantitative Ultrasound Device Improve Discrimination of Hip Fracture?" (abstract) Journal of Bone and Mineral Research, 1999, vol. 14, No. 4.

2.    Barkman et al., "A New Method for Quantitative Measurements at Multiple Skeletal  Sites First Results of Precision and Fracture Discrimination." J. Clinical Densitometry vol 3 no. 1, 1-7, spring 2000.

3.    Knapp et al. "Multipe Site Ultrasound Measurements Predict Vertebral Fractures in Postmenopausal Women" (abstract), presented at the ASBMR 21st Annual Meeting in St. Louis, MI, USA, September 1999.

4.    Knapp et al. "Ultrasound Measurements at the Radius Predict Wrist Fractures in Postmenopausal Women" (abstract), presented at the Annual Meeting of the Bone and Tooth Society in Bristol, UK, June 1999.

5.    Knapp, K et al. "Preliminary Results Of The Sunlight Omnisense Bon Sonometer:  In-Vivo And In-Vitro Precision And Correlation With Dxa." (abstract), presented at the ASBMR-IBMS 2nd Joint Meeting, California, USA, December, 1998.

6.    Weiss M, Ben Shlomo A, Hagag P, Ish-Shalom S. "Discrimination of Proximal Hip Fracture Measurement At The Radius."  Osteoporosis Int, 2000, 11:411-416.

7.    Bouxsein, ML et al., "Prediction of Femoral Failure Load from Femoral BMD and Ultrasonic Velocity at the Femur, Radius and Phalanx" (abstract), presented at the ASBMR 21st Annual Meeting in St. Louis, MI, USA, September 1999.

8.    United States.  Dept. of Health and Human Services. P990035.  Washington:  Food and Drug Administration, 2000.

9.    Weiss et al. "Effect of Estrogen Replacement Therapy on Speed of Sound at Multiple Skeletal Sites."  Maturitas, 35 (2000) 237-243.

Osteoporosis
Bone Densitometry
''For better prevention, detection, diagnosis,
and treatments of Osteoporosis''
278 S. Lincoln St., Minster, OH 45865
Phone: 1-888-999-4774
Fax: 1-419-628-4005
Email: info@bonedensitometry.com

"As president, I have committed my company to providing medical facilities with "state-of-the-art" bone densitometry equipment to help them do a better job with preventing, testing for, screening for, detecting, diagnosing, and treating Osteoporosis which ravage so many women and men. Our diagnostic equipment will speed up the prevention, detection, diagnosis, and treatment of Osteoporosis and osteoporotic bone disorders in men and women. The key to preventing Osteoporosis in women and men is early detection, diagnosis, and treatment. This means measuring, testing, screening, detecting, and diagnosing low bone mass in women and men early in their lifetimes so that effective treatment can stop the Osteoporosis dead in its tracks." Together, we can help protect families from this terrible disease.

Sincerely,
Mark Piening

GOTO HOME PAGE